Similar articles

• Treatment of subacute sclerosing panencephalitis with 5-bromo-2-deoxyuridine and pyran copolymer.

  Freeman JM. Freeman JM. Neurology. 1968 Jan;18(1 Pt 2):176-92. doi: 10.1212/wnl.18.1_part_2.176. Neurology. 1968. PMID: 4170003 No abstract available.
• The clinical spectrum and early diagnosis of Dawson's encephalitis, with preliminary notes on treatment.

  Freeman JM. Freeman JM. J Pediatr. 1969 Oct;75(4):590-603. doi: 10.1016/s0022-3476(69)80454-3. J Pediatr. 1969. PMID: 4185707 No abstract available.
• Treatment of Dawson's encephalitis wit5-bromo-2'-deoxyuridine. Double-blind study.

  Freeman JM. Freeman JM. Arch Neurol. 1969 Oct;21(4):431-4. doi: 10.1001/archneur.1969.00480160103012. Arch Neurol. 1969. PMID: 4186002 Clinical Trial. No abstract available.
• Reflections on the etiology and pathogenesis of subacute sclerosing panencephalitis.

  Zeman W, Kolar O. Zeman W, et al. Neurology. 1968 Jan;18(1 Pt 2):1-7. doi: 10.1212/wnl.18.1_part_2.1. Neurology. 1968. PMID: 4866043 Review. No abstract available.
• Demyelinating diseases and certain virus infections.

  Adams JM. Adams JM. Pathobiol Annu. 1972;2:183-205. Pathobiol Annu. 1972. PMID: 4359244 Review. No abstract available.